• Les progrès de la recherche sont l'unique espoir pour les patients de trouver des thérapies efficaces!

  • Soutenez la recherche dans le domaine des maladies génétiques rares!

Advances in skeletal muscle biology in health and disease

Gainesville, 6-8 march 2019

This conference is well suited for informal interactions and the presentation of data that might be too preliminary for a larger audience. Overall, the goal is to facilitate advances in skeletal muscle biology through discussions that promote new ideas, research lines, and collaborations.

Abstract submission: 10 January 2019

*****************************************************

Rapport d'atelier ENMC

Bone protective therapy in DMD. 1-3 June 2018

disponible en anglais

************************************************************

12th Swiss Meeting on Muscle Research

Magglingen, 4-6 November 2018

This meeting offers an excellent opportunity to interact with researchers working on muscle physiology and pathology and working in Switzerland.
Registration and abstract submission until September 1st

*************************************************************************************

Grant opportunity on DM1 research

The Myotonic Dystrophy Foundation is pleased to announce a Request for Applications (RFA) for the Development of a Genome Editing Strategy for Myotonic Dystrophy Type 1. MDF intends to issue two 2-year awards of up to $250,000 total cost each for projects that address the evaluation of genome editing strategies for DM1 that target the DMPK gene.

More info

Distinct patterns of skeletal muscle mitochondria fusion, fission and mitophagy upon duration of exercise training.

Arribat Y, Broskey NT, Greggio C, Boutant M, Conde Alonso S, Kulkarni SS, Lagarrigue S, Carnero EA, Besson C, Cantó C, Amati F.
Acta Physiol (Oxf). 2018 Aug 24:e13179.

02 septembre 2018

STAC3 variants cause a congenital myopathy with distinctive dysmorphic features and malignant hyperthermia susceptibility.

Zaharieva I, Sarkozy A, Munot P, Manzur A, et al.
Hum Mutat. 2018 Aug 31.

31 août 2018

Muscle Wasting Diseases: Novel Targets and Treatments.

Furrer R, Handschin C.
Annu Rev Pharmacol Toxicol. 2018 Aug 27

27 août 2018

Residual force enhancement contributes to increased performance during stretch-shortening cycles of human plantar flexor muscles in vivo.

Hahn D, Riedel TN.
J Biomech. 2018 Aug 22;77:190-193

22 août 2018